Y-Trap's Rishi Bedi on how predictive & generative AI are changing drug development
- blonca9
- Nov 5, 2023
- 1 min read
Rishi Bedi explains how AI might be impacting protein design, genetic medicine, immuno-oncology and more in the future.
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.